The Binding Site Inc

The Binding Site Inc is a leading provider of diagnostic products and solutions for laboratory professionals around the world. With a history dating back to the early 1970s, the company has established itself as a pioneer in the field of antibody production and immunodiagnostic assays. The Binding Site Inc's team of experts works closely with researchers and clinicians to develop innovative solutions that meet the evolving needs of the medical community. The company's product portfolio includes a range of highly sensitive and highly specific antibodies used for the detection of certain cancers and other serious disorders. The Binding Site Inc is committed to providing high-quality products and services that improve the diagnosis and management of diseases, and its partnership with leading research institutions has further enhanced its capabilities and reach.

At Binding Site we constantly strive to improve the tools available to laboratory professionals around the world for diagnosing and monitoring disease. Our origins date back to a group of researchers within the Medical School of Birmingham University who first started looking at innovative ways of producing antibodies in the early 1970's. With a desire to continue this early work but lacking the required government funding they founded a private company to take the research forward and utilise any potential commercial benefits. That company has evolved into The Binding Site and for over 25 years we have specialised in producing highly sensitive and highly specific antibodies used for the detection of certain cancers and other serious disorders.

We have built our business on the firm foundations of scientific evidence and the willingness and ability to respond to the requirements of researchers and clinicians alike. With our roots firmly planted in the clinical application of laboratory diagnostics we have never lost sight of the ultimate beneficiary of our products - the patient.